Trials / Completed
CompletedNCT02283671
Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Sara Varea · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
First in human study to assess the tolerability and safety profile of treatment with dendritic cell in patients with multiple sclerosis or neuromyelitis optica.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tolerogenic Dendritic cells loaded with myelin peptides | Somatic-cell therapy medicines application |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2019-07-10
- Completion
- 2019-07-10
- First posted
- 2014-11-05
- Last updated
- 2020-02-27
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02283671. Inclusion in this directory is not an endorsement.